Immunocore Holdings plc
IMCR- Exchange
- Nasdaq
- Industry
- Biological Products, (No Diagnostic Substances)
- SEC CIK
- 0001671927
No open-market purchases or sales by Immunocore Holdings plc insiders were filed in the last 90 days; 135 institutions reported holding it in 13F filings for Q2 2026, worth $1.65B in total; no superinvestor holds it.
13F holders, Q2 2022
Institutional positions in Immunocore Holdings plc as of Jun 30, 2022. Investment managers with $100 million or more in US stocks report their long positions on Form 13F within 45 days after each quarter ends. How 13F works
- Institutional holders
- 66
- +9 vs. Q1 2022
- Shares held
- 21.0M
- +1.30M (+6.6%) vs. Q1 2022
- Total value
- $784.5M
- +$194.4M (+32.9%) vs. Q1 2022
- New holders
- 14
- 15 more added
- Sold out
- 5
- 18 more reduced
Compare with Q1 2022: new holders, sold out and not filed yet
Holders and value by quarter
Institutions reporting IMCR on Form 13F each quarter since Q1 2021, and the total value they reported. Values are as of each quarter end, so they also move with the share price.
| Quarter | Holders | Value |
|---|---|---|
| Q2 2026 | 135 | $1.65B |
| Q1 2026 | 142 | $1.58B |
| Q4 2025 | 149 | $1.79B |
| Q3 2025 | 133 | $1.79B |
| Q2 2025 | 134 | $1.50B |
| Q1 2025 | 117 | $1.40B |
| Q4 2024 | 116 | $1.34B |
| Q3 2024 | 130 | $1.41B |
| Q2 2024 | 139 | $1.46B |
| Q1 2024 | 149 | $2.68B |
| Q4 2023 | 133 | $2.56B |
| Q3 2023 | 125 | $1.92B |
| Q2 2023 | 120 | $2.12B |
| Q1 2023 | 109 | $1.61B |
| Q4 2022 | 104 | $1.73B |
| Q3 2022 | 86 | $1.25B |
| Q2 2022 | 66 | $784.5M |
| Q1 2022 | 57 | $590.1M |
| Q4 2021 | 49 | $642.4M |
| Q3 2021 | 47 | $617.4M |
| Q2 2021 | 45 | $561.1M |
| Q1 2021 | 41 | $597.8M |
Institutions, Q2 2022
Shares, value and share of portfolio for each institution holding Immunocore Holdings plc; share changes are against Q1 2022.
| Institution | Shares | Value | % of portfolio | Change in shares | Action |
|---|---|---|---|---|---|
| RTW Investments, LP | 3,996,154 | $149.1M | 3.85% | +2,136,683+114.9% | Added |
| Rock Springs Capital Management LP | 2,671,652 | $99.7M | 2.90% | +119,618+4.7% | Added |
| Baker Bros. Advisors LP | 2,520,730 | $94.0M | 0.53% | 00.0% | Unchanged |
| FMR LLC | 1,360,384 | $50.8M | 0.01% | −267,171−16.4% | Reduced |
| Avidity Partners Management LP | 1,350,000 | $50.4M | 1.16% | −13,800−1.0% | Reduced |
| Wellington Management Group LLP | 1,265,912 | $47.2M | 0.01% | −76,447−5.7% | Reduced |
| General Atlantic LLC | 950,000 | $35.4M | 0.46% | 00.0% | Unchanged |
| First Manhattan Co | 795,849 | $29.7M | 0.12% | −12,700−1.6% | Reduced |
| Paradigm Biocapital Advisors LP | 667,417 | $24.9M | 4.97% | +168,227+33.7% | Added |
| Bill & Melinda Gates Foundation | 576,923 | $21.5M | 16.53% | 00.0% | Unchanged |
| BlackRock Inc. | 496,182 | $18.5M | 0.00% | 00.0% | Unchanged |
| Tang Capital Management LLC | 385,600 | $14.4M | 2.18% | 00.0% | Unchanged |
| Thrivent Financial for Lutherans | 369,504 | $13.8M | 0.04% | −18,190−4.7% | Reduced |
| Massachusetts Financial Services Co | 339,942 | $12.7M | 0.00% | −2,536−0.7% | Reduced |
| Price T Rowe Associates Inc | 313,899 | $11.7M | 0.00% | −29,380−8.6% | Reduced |
| Principal Financial Group Inc | 299,950 | $11.2M | 0.01% | +64,405+27.3% | Added |
| Velan Capital Investment Management LP | 293,385 | $10.9M | 11.60% | 00.0% | Unchanged |
| Schroder Investment Management Group | 280,361 | $10.1M | 0.02% | 00.0% | Unchanged |
| Armistice Capital, LLC | 268,000 | $10.0M | 0.26% | +88,000+48.9% | Added |
| Bain Capital Public Equity Management II, LLC | 249,318 | $9.30M | 0.54% | −68,358−21.5% | Reduced |
| Rathbone Brothers plc | 190,015 | $7.09M | 0.08% | 00.0% | Unchanged |
| Samsara BioCapital, LLC | 160,963 | $6.01M | 1.61% | 00.0% | Unchanged |
| Rhenman & Partners Asset Management AB | 140,000 | $5.22M | 0.59% | −30,472−17.9% | Reduced |
| OrbiMed Advisors LLC | 131,100 | $4.89M | 0.10% | +3,000+2.3% | Added |
| Pier Capital, LLC | 123,394 | $4.60M | 0.79% | −113,222−47.9% | Reduced |
| Citadel Advisors LLC | 84,500 | $3.15M | 0.00% | +24,774+41.5% | Added |
| CWM, LLC | 73,036 | $2.73M | 0.02% | +73,036 | New |
| UBS Oconnor LLC | 57,497 | $2.15M | 0.02% | +57,497 | New |
| Susquehanna International Group, LLP | 57,409 | $2.14M | 0.00% | +57,409 | New |
| Omega Fund Management, LLC | 51,535 | $1.92M | 0.61% | 00.0% | Unchanged |
| Renaissance Technologies LLC | 50,900 | $1.90M | 0.00% | +43,600+597.3% | Added |
| Jane Street Group, LLC | 48,464 | $1.81M | 0.00% | +48,464 | New |
| Cubist Systematic Strategies, LLC | 42,009 | $1.57M | 0.01% | +41,321+6,006.0% | Added |
| TD Asset Management Inc | 27,506 | $1.03M | 0.00% | 00.0% | Unchanged |
| Waverton Investment Management Ltd | 27,330 | $1.02M | 0.04% | −10,000−26.8% | Reduced |
| Alps Advisors Inc | 25,526 | $952.0K | 0.01% | −18,700−42.3% | Reduced |
| Schonfeld Strategic Advisors LLC | 25,200 | $940.0K | 0.01% | +25,200 | New |
| Marshall Wace, LLP | 24,120 | $900.0K | 0.00% | 00.0% | Unchanged |
| Morgan Stanley | 23,347 | $871.0K | 0.00% | +20,995+892.6% | Added |
| Vident Investment Advisory, LLC | 22,912 | $854.0K | 0.03% | −13,899−37.8% | Reduced |
| Manufacturers Life Insurance Company, The | 21,793 | $782.4K | 0.00% | 00.0% | Unchanged |
| Millennium Management LLC | 19,178 | $716.0K | 0.00% | +19,178 | New |
| Geode Capital Management, LLC | 16,464 | $614.0K | 0.00% | +6,989+73.8% | Added |
| Legal & General Group Plc | 15,792 | $589.0K | 0.00% | −6,577−29.4% | Reduced |
| LMR Partners LLP | 15,000 | $560.0K | 0.01% | +15,000 | New |
| ETF Managers Group, LLC | 13,858 | $498.0K | 0.01% | +324+2.4% | Added |
| Jump Financial, LLC | 13,200 | $492.0K | 0.02% | +13,200 | New |
| JPMorgan Chase & Co | 13,106 | $489.0K | 0.00% | +13,106 | New |
| State Street Corp | 11,834 | $442.0K | 0.00% | +11,834 | New |
| Dalton Investments LLC | 10,000 | $373.0K | 0.34% | +10,000 | New |
| Parallax Volatility Advisers, L.P. | 8,556 | $319.0K | 0.00% | +8,556 | New |
| Virtus ETF Advisers LLC | 8,513 | $318.0K | 0.12% | +3,297+63.2% | Added |
| Victory Capital Management Inc | 8,186 | $305.0K | 0.00% | 00.0% | Unchanged |
| UBS Group AG | 7,096 | $265.0K | 0.00% | −1,312−15.6% | Reduced |
| Pura Vida Investments, LLC | 6,419 | $239.0K | 0.04% | +6,419 | New |
| Zurcher Kantonalbank (Zurich Cantonalbank) | 3,864 | $144.0K | 0.00% | 00.0% | Unchanged |
| Bank of America Corp | 2,813 | $105.0K | 0.00% | −4,019−58.8% | Reduced |
| Royal Bank of Canada | 2,658 | $99.0K | 0.00% | 00.0% | Unchanged |
| Barclays PLC | 776 | $29.0K | 0.00% | −332−30.0% | Reduced |
| Advisor Group Holdings, Inc. | 584 | $21.0K | 0.00% | 00.0% | Unchanged |
| Veritas Investment Partners (UK) Ltd. | 575 | $21.0K | 0.00% | 00.0% | Unchanged |
| Simplex Trading, LLC | 500 | $18.0K | 0.00% | −186−27.1% | Reduced |
| Tower Research Capital LLC (TRC) | 285 | $11.0K | 0.00% | +285 | New |
| State of Wyoming | 215 | $8.00K | 0.00% | +52+31.9% | Added |
| Assetmark, Inc | 219 | $8.00K | 0.00% | +125+133.0% | Added |
| Beacon Capital Management, LLC | 250 | $7.00K | 0.00% | 00.0% | Unchanged |
| Point72 Asset Management, L.P. | 0 | $0 | 0.00% | −407,058−100.0% | Sold out |
| Samlyn Capital, LLC | 0 | $0 | 0.00% | −380,811−100.0% | Sold out |
| Artal Group S.A. | 0 | $0 | 0.00% | −200,000−100.0% | Sold out |
| DAFNA Capital Management LLC | 0 | $0 | 0.00% | −53,878−100.0% | Sold out |
| Balyasny Asset Management LLC | 0 | $0 | 0.00% | −52,174−100.0% | Sold out |